Are you interested in using microphysiological systems in your research?  Check out the new NA3RsC MPS Hub, a new, user-friendly resource for you that highlights MPS providers with commercially available technologies.  In this hub, you can quickly sort by organ-type(s) offered, access top 3 publications, links to company websites, and find contact information. And you’ll know that all members are supporters…

Last week we had the pleasure to host our partners from Roche Basel in the first Biochip Storming AX event. Throughout the different sessions, we addressed the challenges and opportunities of the organ-on-chip technology within the drug development pipeline. Thanks to Lauriane CABON and all the participants for making it such as successful day, full of exciting…

We are proud to be part of The North American 3Rs Collaborative’s (NA3RsC) Micro Physiological Systems (MPS) initiative. The MPS initiative works together to increase industry adoption and regulatory acceptance of MPS technologies with the ultimate goal of refining, reducing, and replacing research animals. Learn more about our efforts in this group on the NA3RsC…

Congratulations to Lea de Maddalena for winning the Best Poster Award at EUROoCS2021 Conference! Thank you to the organizing team Maria Tenje from Uppsala University for this excellent panel of speakers and very interesting talks. It was a pleasure to connect with the participants and we are looking forward to next year’s conference.

We are thrilled to be part of the new BRIDGE Discovery project granted by the SNSF Swiss National Science Foundation and Innosuisse to the Laboratory of Microbiology at the Université de Neuchâtel (LAMUN) in cooperation with the CHUV / Centre hospitalier universitaire vaudois, the SIB Swiss Institute of Bioinformatics, and SiMPLInext SA.  The project led by Prof. Pilar Junier aims at establishing a novel solution to the burden imposed by raising antibiotic resistance by applying the innovative concept of “environmental interference” to human…

Despite the covid-19 crisis and no mega-rounds of investment in 2020, Biotech start-ups are back at the top!Swiss Biotech startups collected more than CHF 800 million in 2020, an increase of 31% compared to 2019. This is linked to the fact that innovation in drug development is taking place in the long term and, to…

We are very excited to welcome Léa Todeschini as Business Developer in our team! Léa will be responsible for the growth and development of new business while maintaining customer relationships. We are looking forward to grow and further develop our company together with Léa. If you happen to be near our office, stop by and…

Here is the team behind the scene! Big thanks to Innosuisse for their support and helping us bringing our chip one step closer to society.Check out the article: Reproducing pulmonary function in the lab Video: © Innosuisse / FDFA Presence Switzerland